TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lymphoma patients? early trial combines targeted drug with standard chemo
Disease control TerminatedThis early-phase trial is testing whether adding the targeted drug zanubrutinib to standard chemotherapy (R-PolaCHP) is safe and effective for people with newly diagnosed diffuse large B-cell lymphoma. About 38 adults will take part. The goal is to find the best dose and watch fo…
Matched conditions: TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Yazeed Sawalha • Aim: Disease control
Last updated May 26, 2026 07:28 UTC
-
Could an oral drug boost chemo for seniors with lymphoma?
Disease control OngoingThis study looks at whether adding an oral medication (CC-486, or oral azacitidine) to a standard reduced-dose chemo regimen (R-miniCHOP) can help people aged 75 and older with newly diagnosed aggressive B-cell lymphomas. The goal is to see if the combination improves how long pa…
Matched conditions: TRANSFORMED MARGINAL ZONE LYMPHOMA TO DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:53 UTC